Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 9 Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasm Metastasis 4 Solid Tumors 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Solid Tumor, Adult 1 Prostatic Neoplasms 1 Kidney Neoplasms 1 KRAS and NRAS Wild-type Colorectal Cancer 1 Head and Neck Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Adenosquamous 1 Carcinoma 1 Advanced Solid Tumors 1

Interventions

pembrolizumab 3 Cyclophosphamide 3 fludarabine 2 Rosuvastatin Calcium 2 Radiotherapy 2 Paclitaxel 2 Ipilimumab 2 Interleukin-2 2 Carboplatin 2 spartalizumab 1 peposertib 1 osimertinib 1 niraparib 1 neotil 1 necitumumab 1 mirdametinib 1 apatinib 1 amivantamab 1 Valganciclovir 1 Tomography, X-Ray Computed 1 Rifampin 1 Radiation 1 Positron-Emission Tomography 1 PankoMab-GEX 1 Panitumumab 1 Nivolumab 1 Midazolam 1 Metformin 1 Magnetic Resonance Imaging 1 MEK inhibitor I 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Solid Tumor, Adult × Panitumumab × Clear all

NCT03360734 2021-07-12

GATTO

Glycotope GmbH

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡